OmniVis

Startup
Summarized by Halo AI

OmniVis is a biotechnology company providing handheld, smartphone-enabled diagnostic devices that deliver rapid, lab-grade detection of foodborne and waterborne pathogens in under 30 minutes, designed for use by aid workers and food safety teams.

Founded & HQ
South San Francisco, CA, USA
Company size
1-10 employees
Funding
~$3.3M
IP status
2 patents filed · 6 grants confirmed
Activity highlights
Received a $100,000 investment from the Purdue Ag-Celerator fund to establish a field pilot for its iSpyDx pathogen detection device.

A biotechnology startup founded in 2017, OmniVis originated from academic research in detecting cholera. It focuses on accessible diagnostics to make pathogen testing rapid and simple. The team blends expertise in bioengineering and app development, aiming to bring lab-grade testing to even low-resource or industrial settings.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Sponsored researchCo-developmentPilot or trial engagement

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.